Schedule 13D ownership disclosure

CELLULAR BIOMEDICINE GROUP I

Security class unavailable · CUSIP: 15117P102

Event date: 2016-02-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
16.1100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001354488-16-007881
Form type
SC 13D
Filer
Cellular Biomedicine Group, Inc.
CIK
CIK 1378624
Filed
Jun 23, 2016
Reporting period
Feb 04, 2016
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub